Inventor

John W. Shell

Inventor

Hillsborough, CA, US

Overview

23→

Patents

1976–2018

Patent span

Human necessities

Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes63%

A61FFilters implantable into blood vessels20%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%

Y02ATechnologies for adaptation to climate change6%

B82YSpecific uses or applications of nanostructures3%

PatentTitleYear

9,980,903Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract2018 7,976,870'Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract'2011 7,405,238'Pharmacological inducement of the fed mode for enhanced drug administration to the stomach'2008 6,635,280'Extending the duration of drug release within the stomach during the fed mode'2003 6,340,475'Extending the duration of drug release within the stomach during the fed mode'2002 5,972,389'Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter'1999 5,582,837'Alkyl-substituted cellulose-based sustained-release oral drug dosage forms'1996 5,011,843'Treatment of glaucoma using phosphodiesterase inhibitors'1991 5,007,790'Sustained-release oral drug dosage form'1991 4,975,428'Treatment of glaucoma using phosphodiesterase inhibitors'1990 4,478,818'Ocular preparation housing steroid in two different therapeutic forms'1984 4,432,964'Topical composition containing steroid in two forms released independently from polymeric carrier'1984 4,304,765'Ocular insert housing steroid in two different therapeutic forms'1981 4,303,637'Medication indicated for ocular hypertension'1981 4,281,654'Drug delivery system for controlled ocular therapy'1981 4,173,226'Device for administering solid drug particles to an eye'1979 4,115,544'Ocular system made of bioerodible esters having linear ether'1978 4,001,388'Ophthalmological bioerodible drug dispensing formulation'1977 3,995,635'Ocular insert'1976 3,993,071'Bioerodible ocular device'1976 3,986,510'Bioerodible ocular device'1976 3,981,303'Bioerodible ocular device'1976 3,960,150'Bioerodible ocular device'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1984Patents assigned to ALZA CORP (13)· patent assignee history

1976–1978Based in Los Altos, CA, US· patent location history

1979–2018Based in Hillsborough, CA, US· patent location history

1990–1991Patents assigned to IOLAB CORP (2)· patent assignee history

1991Patents assigned to DEPOMED SYSTEMS INC (1)· patent assignee history

1996–2018Patents assigned to DEPOMED INC (7)· patent assignee history

2018Patents assigned to BERNER BRET (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ALZA CORP	13	1976–1984
DEPOMED INC	7	1996–2018
IOLAB CORP	2	1990–1991
BERNER BRET	1	2018
DEPOMED SYSTEMS INC	1	1991

Locations

Location	Patents	Span
Hillsborough, California, US	16	1979–2018
Los Altos, California, US	7	1976–1978